bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.02.13.638029

Staphylococcal Internalization into Osteoblasts: A Partially Conserved Mechanism Across the Genus

Abstract

Staphylococcus aureus, considered as a major human pathogen, is associated with severe infections such as bacteremia, endocarditis, skin and soft tissue infections, and bone and joint infections. Virulence mechanisms, such as biofilm formation and invasion/internalization of/into host cells, support the pathogenicity of S. aureus as they enable it to evade from the immune system and most antibiotic treatments. S. aureus can be internalized into non-professional phagocytic cells like fibroblasts, epithelial cells, endothelial cells and osteoblasts. The main pathway of internalization of S. aureus is FnBP-fibronectin-5{beta}1 integrin dependent. Interestingly, S. pseudintermedius, S. delphini and S. argenteus are able to invade osteoblasts, depending on the presence of FnBP-like proteins such as Staphylococcus pseudintermedius surface proteins D and L (SpsD/L) or Staphylococcus delphini surface protein Y (SdsY). However, the internalization capacity and mechanism have been poorly investigated in other staphylococci species. Here, we investigated the internalization capacity of staphylococci into osteoblasts at the genus level and attempted to correlate it with the presence of FnBP-like proteins by combining fibronectin adhesion assays, infection of osteoblasts and genome analysis. Over the 53 Staphylococcus species tested, half of them exhibited high internalization into osteoblasts. We highlighted that the "FnBP-fibronectin-5{beta}1 integrin" dependent internalization pathway of S. aureus, is well-conserved in 27 Staphylococcus species. In silico analysis identified multiple FnBP-like proteins correlating with the highly internalized species and showing diversity in their sequence organization, likely due to multiple acquisitions of such encoding genes throughout Staphylococcus evolution. AUTHOR SUMMARYStaphylococcus aureus is a pathogenic bacterium that causes severe infections including bone and joint infections. It invades bone cells, such as osteoblasts, using the bacterial surface protein FnBP, which binds to fibronectin, an extracellular compound, which subsequently binds to 5{beta}1 integrin on the surface of osteoblasts. This cross-linking enables active internalization of S. aureus by the cells and potential intracellular persistence, which are responsible for the ability to induce staphylococcal chronic infections. While four species have been studied for their internalization into osteoblasts, a comprehensive genus-level investigation remains unexplored. Therefore, we investigated the conservation of this internalization capacity among the genus Staphylococcus, including a significant number of species of animal origin. Approximately half of the genus is capable of invading osteoblasts at varying levels via 5{beta}1 integrin. Additionally, homologous proteins to FnBP were identified in most highly internalized species, suggesting a similar pathway of cell internalization to that of S. aureus. Genomic analysis reveals these proteins were acquired multiple times during evolution, suggesting they provide an advantage for host infection. In the context of One Health approach and the increasing number of animal pathogens causing human infections, understanding staphylococcal pathogenicity will help anticipate the emergence of new infectious diseases.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Crepin, D. M., Bonhomme, M., Faure, A., Sinel, C., Bergot, M., Dyon-Tafani, V., Maali, Y., Bouvard, D., Diot, A., Laurent, F., Josse, J.. 2025-02-13. Staphylococcal Internalization into Osteoblasts: A Partially Conserved Mechanism Across the Genus. https://doi.org/10.1101/2025.02.13.638029

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗